arrow
O

Ornella Garrone

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
H指数:38
被引数:7,123

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of dose-dense adjuvant chemotherapy in patients with node-positive early breast cancer according to estrogen receptor levels: an exploratory analysis of the GIM2 trial

根据雌激素受体水平,剂量密集型辅助化疗对淋巴结阳性早期乳腺癌患者的影响:GIM2试验的探索性分析

Breast
IF7.9
2026-09-290
OA
Broad baseline-variable profiling of visceral conversion in bone-only HR+/ HER2-metastatic breast cancer treated with CDK4/6 inhibitors

骨转移性HR+/HER2-转移性乳腺癌经CDK4/6抑制剂治疗后腹腔转化的大范围基线-变量分析

2026-09-011
OA
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone Metastases

CDK4/6抑制剂在HR+/HER2-骨转移性乳腺癌患者中的真实世界无进展生存比较

2026-05-010
OA
Does Glucose-6-Phosphate Dehydrogenase Deficiency Correlate with Increased Sensitivity to Cisplatin? A Case Report and a Narrative Literature Review

葡萄糖-6-磷酸脱氢酶缺乏症是否与顺铂敏感性增加相关?病例报告及文献综述

2026-04-270
OAAI
Preliminary report on advanced biliary cancer patients receiving multimodality treatment in the immunotherapy era: a real-world multicentre experience

关于免疫治疗时代接受多模式治疗的晚期胆道癌患者的初步报告:一项真实世界多中心经验

2026-03-190
OA
DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists

DonnaRosa 项目:探索乳腺癌专家之间的非正式沟通实践

2025-12-140
OAAI
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial☆

肿瘤浸润淋巴细胞与BMI在早期HER2阳性乳腺癌中的相互作用:ShortHER试验分析☆

2025-10-100
OAAI
Correction: Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review

更正:基于放射治疗或放射性核素组合的治疗方案以提高免疫疗法在晚期前列腺癌中的疗效:一项系统评价

2025-09-160
OA